Please provide your email address to receive an email when new articles are posted on . In a study of patients with endometrial stromal sarcomas treated with aromatase inhibitors the objective ...
Phase II trial assessing niraparib with or without dostarlimab (anti-PD-1) in recurrent endometrial carcinoma. Open-label, multicenter, phase 1b/2 study of rebastinib in combination with paclitaxel to ...
Recent advances in the biological and molecular understanding of rare uterine tumors have expanded therapeutic options for patients. Uterine cancers are a highly heterogeneous group of cancers that ...
The conversation often begins with subtle changes that women might initially dismiss as normal variations in their monthly cycle. Perhaps unusual bleeding between periods, or discharge that seems ...
Prevalence of Pathogenic Germline Variants in Patients With Gastric Cancer Ascertained Through Multigene Panel Testing The molecular heterogeneity of endometrial stromal tumors (ESTs) is demonstrated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results